Hindustan Zinc Ltd
NSE:HINDZINC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
289.4
772.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Hindustan Zinc Ltd
Current Assets | 104.7B |
Cash & Short-Term Investments | 79.1B |
Receivables | 2.8B |
Other Current Assets | 22.8B |
Non-Current Assets | 220.9B |
Long-Term Investments | 9B |
PP&E | 201.7B |
Intangibles | 2.3B |
Other Non-Current Assets | 7.8B |
Current Liabilities | 171B |
Accounts Payable | 23.9B |
Other Current Liabilities | 147.1B |
Non-Current Liabilities | 78.3B |
Long-Term Debt | 44.6B |
Other Non-Current Liabilities | 33.7B |
Balance Sheet
Hindustan Zinc Ltd
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
500
|
510
|
1 890
|
1 730
|
20
|
18 780
|
3 130
|
15 920
|
590
|
530
|
|
Cash |
280
|
510
|
1 890
|
1 730
|
20
|
500
|
1 330
|
820
|
590
|
530
|
|
Cash Equivalents |
220
|
0
|
0
|
0
|
0
|
18 280
|
1 800
|
15 100
|
0
|
0
|
|
Short-Term Investments |
308 480
|
352 210
|
237 830
|
202 220
|
194 880
|
203 490
|
220 440
|
192 290
|
98 500
|
99 670
|
|
Total Receivables |
6 310
|
1 800
|
2 050
|
2 640
|
2 410
|
4 450
|
6 910
|
10 750
|
16 010
|
5 460
|
|
Accounts Receivables |
5 600
|
1 070
|
1 360
|
1 840
|
1 960
|
4 010
|
4 080
|
7 160
|
3 830
|
1 620
|
|
Other Receivables |
710
|
730
|
690
|
800
|
450
|
440
|
2 830
|
3 590
|
12 180
|
3 840
|
|
Inventory |
13 280
|
12 470
|
20 630
|
16 300
|
17 380
|
19 200
|
14 930
|
20 590
|
19 090
|
20 190
|
|
Other Current Assets |
2 270
|
2 140
|
84 090
|
18 540
|
1 030
|
2 210
|
270
|
270
|
13 850
|
400
|
|
Total Current Assets |
330 840
|
369 130
|
346 490
|
241 430
|
215 720
|
248 130
|
245 680
|
239 820
|
148 040
|
126 250
|
|
PP&E Net |
117 880
|
126 930
|
129 360
|
144 010
|
169 220
|
187 060
|
183 690
|
192 400
|
197 670
|
196 670
|
|
PP&E Gross |
117 880
|
126 930
|
129 360
|
144 010
|
169 220
|
187 060
|
183 690
|
192 400
|
197 670
|
196 670
|
|
Accumulated Depreciation |
53 850
|
61 030
|
78 640
|
92 950
|
109 900
|
130 620
|
154 000
|
178 720
|
204 830
|
237 410
|
|
Intangible Assets |
1 170
|
1 200
|
1 280
|
1 210
|
1 100
|
2 520
|
3 610
|
2 310
|
920
|
1 800
|
|
Note Receivable |
5 200
|
5 360
|
11 930
|
19 210
|
17 960
|
13 780
|
13 280
|
11 610
|
4 350
|
7 140
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
40
|
40
|
50
|
2 620
|
5 830
|
|
Other Long-Term Assets |
14 930
|
29 330
|
28 890
|
23 460
|
20 580
|
18 220
|
10 970
|
510
|
1 070
|
1 260
|
|
Total Assets |
470 020
N/A
|
531 950
+13%
|
517 950
-3%
|
429 320
-17%
|
424 580
-1%
|
469 750
+11%
|
457 270
-3%
|
446 700
-2%
|
354 670
-21%
|
338 950
-4%
|
|
Liabilities | |||||||||||
Accounts Payable |
7 620
|
9 310
|
8 240
|
9 470
|
11 740
|
14 880
|
15 450
|
20 380
|
20 880
|
21 060
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
10
|
1 010
|
760
|
780
|
840
|
|
Short-Term Debt |
0
|
0
|
79 080
|
0
|
25 380
|
6 110
|
21 610
|
90
|
82 300
|
15 120
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
60
|
7 200
|
7 180
|
21 320
|
27 860
|
|
Other Current Liabilities |
9 160
|
141 960
|
114 980
|
50 580
|
40 320
|
33 070
|
33 490
|
32 530
|
49 250
|
43 530
|
|
Total Current Liabilities |
16 780
|
151 270
|
202 300
|
60 050
|
77 440
|
54 130
|
78 760
|
60 940
|
174 530
|
108 410
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
220
|
43 200
|
21 170
|
15 190
|
44 240
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9 420
|
23 140
|
23 110
|
|
Other Liabilities |
7 030
|
6 830
|
7 600
|
9 950
|
11 090
|
12 300
|
12 180
|
12 360
|
12 490
|
11 240
|
|
Total Liabilities |
23 810
N/A
|
158 100
+564%
|
209 900
+33%
|
70 000
-67%
|
88 530
+26%
|
66 650
-25%
|
134 140
+101%
|
103 890
-23%
|
225 350
+117%
|
187 000
-17%
|
|
Equity | |||||||||||
Common Stock |
8 450
|
8 450
|
8 450
|
8 450
|
8 450
|
8 450
|
8 450
|
8 450
|
8 450
|
8 450
|
|
Retained Earnings |
436 870
|
364 450
|
298 070
|
350 160
|
327 600
|
394 650
|
314 680
|
335 000
|
121 170
|
143 780
|
|
Other Equity |
890
|
950
|
1 530
|
710
|
0
|
0
|
0
|
640
|
300
|
280
|
|
Total Equity |
446 210
N/A
|
373 850
-16%
|
308 050
-18%
|
359 320
+17%
|
336 050
-6%
|
403 100
+20%
|
323 130
-20%
|
342 810
+6%
|
129 320
-62%
|
151 950
+17%
|
|
Total Liabilities & Equity |
470 020
N/A
|
531 950
+13%
|
517 950
-3%
|
429 320
-17%
|
424 580
-1%
|
469 750
+11%
|
457 270
-3%
|
446 700
-2%
|
354 670
-21%
|
338 950
-4%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
4 230
|
4 230
|
4 230
|
4 230
|
4 230
|
4 230
|
4 230
|
4 230
|
4 230
|
4 230
|